XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended 12 Months Ended 16 Months Ended 239 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2023
Operating Activities            
Net increase (decrease) in net assets resulting from operations   $ 22,940,000 $ 118,760,000 $ 82,364,000    
Net realized losses (gains) $ (1,034,000) 69,239,000 (200,000) 67,367,000    
Net change in unrealized losses (gains) (1,078,000) (18,036,000) (2,561,000) (53,770,000)    
Net amortization of premiums and accretion of discounts on investments   (6,131,000) (7,751,000) (9,611,000)    
Accretion of discount on notes   453,000 604,000 684,000    
Amortization of deferred financing costs   3,899,000 5,258,000 5,161,000    
Increase in gains/(losses) from foreign currency transactions   273,000 69,000 (5,580,000)    
PIK interest and dividends capitalized   (2,154,000) (2,970,000) (4,318,000)    
Changes in operating assets and liabilities:            
Purchases of investments   (499,632,000) (417,124,000) (1,140,863,000)    
Proceeds from sales and repayments of investments   581,952,000 497,313,000 1,056,937,000    
Decrease (increase) in interest receivable   (1,615,000) (4,273,000) (2,419,000)    
Decrease (increase) in dividends receivable   247,000 3,509,000 (1,290,000)    
Decrease (increase) in prepaid expenses and other assets   (1,078,000) 1,792,000 188,000    
Increase (decrease) in management and performance-based incentive fees payable   (853,000) 1,669,000 1,246,000    
Increase (decrease) in interest payable   10,211,000 948,000 1,239,000    
Increase (decrease) in accrued administrative services expense   (149,000) 909,000 103,000    
Increase (decrease) in other liabilities and accrued expenses   (1,178,000) 429,000 (115,000)    
Net Cash Used in/Provided by Operating Activities   158,388,000 196,381,000 (2,677,000)    
Financing Activities            
Issuances of debt   168,000,000 630,595,000 494,694,000    
Payments of debt   (231,543,000) (655,285,000) (401,250,000)    
Financing costs paid and deferred     (10,896,000) (333,000)    
Net proceeds from the issuance of common stock   30,000,000     $ 0 $ 2,240,067,000
Repurchase of common stock   (1,638,000) (2,297,000) (21,100,000)   (248,107,000)
Distributions paid   (66,724,000) (123,477,000) (93,342,000)    
Net Cash Used in/Provided by Financing Activities   (101,905,000) (161,360,000) (21,331,000)    
Cash, Cash Equivalents and Foreign Currencies            
Net increase (decrease) in cash, cash equivalents and foreign currencies during the period   56,483,000 35,021,000 (24,008,000)    
Effect of foreign exchange rate changes on cash and cash equivalents   10,000 16,000 (18,000)    
Cash, cash equivalents and foreign currencies at beginning of period   30,598,000 87,091,000 54,624,000    
Cash, Cash Equivalents and Foreign Currencies at the End of Period $ 122,128,000 87,091,000 122,128,000 30,598,000 $ 122,128,000 $ 122,128,000
Supplemental Disclosure of Cash Flow Information            
Cash interest paid   44,613,000 97,472,000 47,897,000    
Non-Cash Activity            
PIK income   $ 2,662,000 $ 3,006,000 $ 4,075,000